Glaceum

Glaceum is a biopharmaceutical company focused on discovering and developing new therapies for metabolic diseases, including non-alcoholic steatohepatitis (NASH). Glaceum has introduced a new model for the treatment of metabolic diseases and is developing comprehensive therapies to meet the needs of patients with obesity, liver disease, and type 2 diabetes. Glaceum is committed to providing universal treatment for patients with metabolic diseases by restoring their body's homeostasis.